Showing results (31-40 of 110) with videos related to

Sort By:
Pageof 11
The Oncologist|September 1, 2020
Changes in Stage Distribution and Disease-Specific Survival in Differentiated Thyroid Cancer with Transition to American Joint Committee on Cancer 8th Edition: A Systematic Review and Meta-AnalysisMelissa G Lechner, Angeli C Bernardo, Alyssa Lampe, et al.
Plos One|February 2, 2013
Genetic and pharmacological targeting of CSF-1/CSF-1R inhibits tumor-associated macrophages and impairs BRAF-induced thyroid cancer progressionMabel Ryder, Matti Gild, Tobias M Hohl, et al.
Journal of Translational Medicine|June 11, 2011
Functional characterization of human Cd33+ and Cd11b+ myeloid-derived suppressor cell subsets induced from peripheral blood mononuclear cells co-cultured with a diverse set of human tumor cell linesMelissa G Lechner, Carolina Megiel, Sarah M Russell, et al.
The Oncologist|November 9, 2025
Safety and clinical outcomes of pembrolizumab standard-interval dosing versus extended-interval dosing in patients with breast cancerAlexis LeVee, Austin Kordic, Nora Ruel, et al.
Thyroid : Official Journal of the American Thyroid Association|April 24, 2020
Immune Checkpoint Inhibitor-Induced Thyroiditis Is Associated with Increased Intrathyroidal T Lymphocyte SubpopulationsAnupam Kotwal, Michael P Gustafson, Svetlana Bornschlegl, et al.
Ultrasound in Medicine & Biology|June 7, 2022
Added value of mass characteristic frequency to 2-D shear wave elastography for differentiation of benign and malignant thyroid nodulesJacob Kohlenberg, Juanjuan Gu, Ahmad Parvinian, et al.
Thyroid : Official Journal of the American Thyroid Association|June 24, 2014
BRAF V600E in papillary thyroid carcinoma is associated with increased programmed death ligand 1 expression and suppressive immune cell infiltrationTrevor E Angell, Melissa G Lechner, Julie K Jang, et al.
JCEM Case Reports|June 11, 2026
Severe autoimmunity after checkpoint inhibitor therapy in a patient with autoimmune polyglandular syndrome type 1Alexandra Lim, Esther M Peluso, Ian A Downs, et al.
The Journal of Clinical Endocrinology and Metabolism|June 15, 2017
Pembrolizumab-Induced Thyroiditis: Comprehensive Clinical Review and Insights Into Underlying Involved MechanismsDanae A Delivanis, Michael P Gustafson, Svetlana Bornschlegl, et al.
JCEM Case Reports|February 18, 2025
Medullary Thyroid Carcinoma and Clinical Outcomes in Heterozygous Carriers of the RET K666N Germline Pathogenic VariantAllison T Yip, Teresa H Kim, Esther M Peluso, et al.
Pageof 11